VWM
GILD icon

VCI Wealth Management’s Gilead Sciences GILD Stock Holding History

VCI Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.5M Buy
19,805
+4,122
+26% +$543K 0.63% 41
2026
Q1 		$2.19M Buy
+15,683
New +$2.2M 0.61% 31
2024
Q4 		– Sell
-18,070
Closed -$1.51M – 93
2024
Q3 		$1.51M Buy
+18,070
New +$1.38M 0.67% 41

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VCI Wealth Management's GILD Position: Q2 2026 in Review

VCI Wealth Management increased its Gilead Sciences (GILD) stake by 26% in Q2 2026, buying an estimated $543K and bringing the position to 19,805 shares worth $2.5M. The position accounts for 0.63% of the portfolio, ranked #41.

VCI Wealth Management first reported a position in GILD in Q3 2024 and has held it in 3 quarters since. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • VCI Wealth Management held 19,805 shares of Gilead Sciences worth $2.5M as of Q2 2026.
  • VCI Wealth Management bought 4,122 Gilead Sciences shares in Q2 2026, an estimated $543K.
  • Gilead Sciences made up 0.63% of VCI Wealth Management's portfolio in Q2 2026, its #41 holding.
  • VCI Wealth Management first reported a position in Gilead Sciences in Q3 2024 and has held it in 3 quarters since.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on VCI Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.